Public Sector Partnerships Bionovis has active MoUs with Fiocruz/Farmanguinhos and BahiaFarma/Biocon Biologics for joint R&D and the productive development of Pertuzumab for Brazil’s public health system, signaling readiness for large-scale government procurement and technology-transfer deals.

Oncology Focus The Pertuzumab project targets HER-2 metastatic breast cancer with a substantial annual procurement value, signaling a strong recurring oncology biosimilar demand and opportunities to cross-sell additional cancer therapies.

Tech Transfer Capabilities A prior Samsung Bioepis technology transfer collaboration under the PDP program demonstrates Bionovis’s capacity to absorb and implement complex biologics manufacturing technology, enabling BD conversations around contract development, manufacturing, and supply-for-Brazil or LATAM.

Regional Manufacturing Hub With a Brazil-first strategy and collaborations with public institutions and global partners, Bionovis could serve as a regional hub for biosimilars and biologics in Latin America, offering partners access to local regulatory, manufacturing, and distribution capabilities.

Pipeline Diversification A strategy to build biosimilars, biobetters, and innovative biologics creates multiple cross-selling opportunities across oncology and rare diseases, appealing to global partners seeking local development, manufacturing, and commercialization in Brazil and nearby markets.